Why You Shouldn’t Compare Your Fitness Progress with Others?

11 months ago

Why You Shouldn’t Compare Your Fitness Progress with Others By Sohamjita Roy , It's easy to fall into the trap…

Home Loan EMI vs. Renting: Which is the Better Financial Decision?

11 months ago

Home Loan EMI vs. Renting: Which is the Better Financial Decision? If you’re in your 30s or early 40s, you…

How to Invest Your Monthly Surplus Wisely: A Guide to Achieving Financial Goals

11 months ago

How to Invest Your Monthly Surplus Wisely: A Guide to Achieving Financial Goals? At times, you may find yourself with…

The Connection Between Alzheimer’s and Menopause: What Every Woman Should Know

11 months ago

The Connection Between Alzheimer’s and Menopause: What Every Woman Should Know Alzheimer’s disease affects nearly 50 million people globally, and…

Leading Hidradenitis Suppurativa Treatments in the Market

11 months ago

Leading Hidradenitis Suppurativa Treatments in the Market Currently, some of the top medications for treating hidradenitis suppurativa (HS) include BIMZELX…

Exploring Pharmacokinetic (PK) Data and Strategies for Analysis

11 months ago

Some basics of Pharmacokinetics (PK) analysis: Pharmacokinetics refers to the study of how a drug is absorbed, distributed, metabolized, and eliminated…

From ‘After’ to ‘Before’: Smita Bhatnagar’s Evolution Through TC21

11 months ago

From 'After' to 'Before': Smita Bhatnagar’s Evolution Through TC21 In April 2024, I, Smita Bhatnagar, celebrated a significant milestone in…

Gut Reset? Gut Detox? Gut Cleanse? – What You Need to Know!

11 months ago

Gut Reset? Gut Detox? Gut Cleanse? – What You Need to Know! Author: Prachi Gupta, Coach, Fittr In today’s world,…

Bristol Myers Squibb Advances Opdualag to Phase 3 Trials for Non-Small Cell Lung Cancer

11 months ago

Bristol Myers Squibb Advances Opdualag to Phase 3 Trials for Non-Small Cell Lung Cancer Bristol Myers Squibb (BMS) is set…

Keytruda’s Triumph in Early-Stage Triple-Negative Breast Cancer: A New Standard of Care

11 months ago

Keytruda's Triumph in Early-Stage Triple-Negative Breast Cancer: A New Standard of Care Merck's Keytruda (pembrolizumab) has achieved a significant milestone…